Clemex announces its Financial Results for 2008 - Increase in sales of 6%

    Symbol:  CXG.A-TSX-V
    Shares Outstanding:  20,843,810

    MONTREAL, Aug. 12 /CNW Telbec/ - Clemex Technologies Inc. (TSX
Venture: CXG.a) announces its financial results for Fiscal year 2008 ending
April 30th, 2008. Sales increased by $309,280, or about 6% to reach $5,654,101
compared to $5,344,821 for FY 2007. The Company posts a Net Loss of $227,218,
or $0.012 per share, while it showed a Net Loss of $59,246 or $0.003 per share
last year. Gross Margin increased by 1.5 % from 57.7% in 2007 to 59.2% this
    Sales in North America increased this year despite the economic slowdown
in United States. Sales in Canada however increased by 25% compared to last
year higher while International sales remained about the same at $1,382,754
compared to $1,358,501 the previous year. In the final analysis, the Company's
performance was slowed down by reduced income resulting from the sudden drop
of the US Dollar for the second year in a row and by the slower than expected
launch of the Clemex PS(3), the Company's latest instrument aimed a particle
sizing analysis, designed and targeted for the Pharmaceutical market.
    When asked to comment these yearly results, the president and CEO
declared the following: "Although the company showed an increase in sales, we
remain disappointed with the growth rate. Several initiatives were set forth
in order to establish winning conditions to promote sales, as part of these
initiative; a distribution agreement was reached with an important player on
the international market (Horiba Instruments) for our particle analysis
instrument, in the US and a new market research strategy was implemented in
order to generate new leads and sales in the US. However we must be patient as
the results of these initiatives will have increasing positive impact on the
sales in subsequent years." He continued:" We must also take into account
external factors which affected our profitability, such as the slow American
economy and the relative increase of the Canadian dollar value. These elements
are out of our control. The company also encountered exceptional and non
recurrent administrative expenses for professional services. The negative
effects of such unusual conditions on the profitability of Clemex can only be
diminished with time, as the conjuncture stabilizes, and the company's new
initiatives can then have a positive effect on the growth."

    Financial Highlights
      Fiscal year ended              April 30th, 2008       April 30th, 2007
                                                    $                      $
      Sales                               $ 5,654,101            $ 5,344,821
      Cost of Sales                         2,301,985              2,258,683
                                            ---------              ---------

      Gross Margin                          3,352,116              3,086,138
      Gross Margin %                             59.2%                  57.7%

      Operating Expenses
      Sales & Marketing                     1,646,248              1,595,435
      Administration                        1,051,909                809,220
      R&D                                     472,665                363,147
      Financial                               127,233                118,208
      Amortization                            106,009                108,962
      Loss on foreign exchange                 80,270                 21,912
                                               ------                 ------
                                            3,484,334              3,016,884

      Profit/Loss Before Taxes               (132,218)                69,254

      Income Taxes                             95,000                128,500

    Net Profit/Net (Loss)                    (227,218)               (59,246)
                                             ---------               --------
                                             ---------               --------

    Earnings/(Loss) Per Share                  (0.012)                (0.003)
    Earnings/(Loss)Per Share diluted           (0.012)                (0.003)

    About Clemex Technologies, Inc.

    Clemex Technologies Inc. develops, manufactures and markets image
analysis systems and software used by quality control and research microscopy
laboratories. Clemex customer base spans over many countries in America,
Europe, Asia and encompasses major Research and Development Centers,
prestigious Universities and large manufacturing industries in various fields
including automotive, aerospace, raw materials manufacturing, pharmaceuticals,
mining and other sectors.

    The CDNX has not reviewed and does not accept responsibility for the
    adequacy and accuracy of this news release.

For further information:

For further information: Clément Forget, Clemex Technologies Inc, (450)

Organization Profile

Clemex Technologies Inc.

More on this organization

Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

CNW Membership

Fill out a CNW membership form or contact us at 1 (877) 269-7890

Learn about CNW services

Request more information about CNW products and services or call us at 1 (877) 269-7890